Clin2
NCT05131594Likely a fitEnrolling by invitation

Study immune response in Long COVID patients

COVID-19

Part of Infections, Lungs & breathing clinical trials.

This trial studies how your immune system responds in people with Long COVID after a past COVID-19 infection. It may help researchers understand why symptoms linger and how the body’s response could be targeted.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are enrolled in Huntington Hospital’s Long COVID Recovery Clinic
  • You have documented evidence you previously had COVID-19
  • You currently have Long COVID-type symptoms after COVID
  • You agree to take part by signing the informed consent form
  • You are not currently in jail or prison

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04679584Recruiting
Study of long-term effects after COVID-19 infection

This study looks at how COVID-19 can affect health and quality of life over the long term. It may help researchers understand symptoms that can last and what changes people experience after recovery.

Würzburg, Bavaria
NCT05531773Recruiting
Study for ongoing symptoms after COVID-19

This trial studies people with mild to moderate COVID-19 symptoms to better understand and help “post-COVID” condition (ongoing effects after infection). You may be eligible if you’re an adult with a recent confirmed COVID-19 test and you agreed to take part.

Düsseldorf
NCT06528171Recruiting
Long COVID immunity and imaging study

This trial studies people who had COVID-19 to understand why some develop long-term symptoms while others recover fully. It aims to find links between the immune system and brain changes using imaging.

Nice
NCT06597682Not yet recruiting
Study of treatments for long COVID

This trial is testing treatments for people with long COVID, which is when symptoms last more than 3 months after a COVID-19 infection. The trial focuses on three specific symptom groups: heart inflammation, cough, or severe fatigue with signs of inflammation. It aims to find if certain immune-modulating therapies can help.

Shanghai, Shanghai Municipality
NCT07074158Enrolling by invitation
Looking for long COVID clues in blood

This study compares the blood of people with ongoing long COVID symptoms to healthy people, to look for differences in immune signals and gut bacteria. It could help find better ways to diagnose or treat long COVID.

Palo Alto, California
NCT07757620Not yet recruiting
Gene changes in long covid patients

This study looks at how COVID-19 changes your genes, which might explain why some people have long-lasting symptoms. If you join, you'll provide a blood sample, and the results could help us better understand long COVID.

Cusano Milanino, Milano

Hear when a new COVID-19 trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.